Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man

British Journal of Clinical Pharmacology
A LeloJ O Miners

Abstract

The pharmacokinetics of caffeine (CA), paraxanthine (PX), theobromine (TB) and theophylline (TP) were studied in six healthy male volunteers after oral administration of each compound on separate occasions. The total plasma clearances of CA and PX were similar in value (2.07 and 2.20 ml min-1 kg-1, respectively) as were those for TP and TB (0.93 and 1.20 ml min-1 kg-1, respectively). The unbound plasma clearances of CA and PX were also similar in magnitude (3.11 and 4.14 ml min-1 kg-1, respectively) as were those of TP and TB (1.61 and 1.39 ml min-1 kg-1, respectively). The half-lives of TP and TB (6.2 and 7.2 h, respectively) were significantly longer than those of CA and PX (4.1 and 3.1 h, respectively). The volume of distribution at steady state of TP (0.44 l kg-1) was lower than that of the other methylxanthines (0.63-0.72 l kg-1). The unbound volume of distribution of TP (0.77 l kg-1) was however the same as that of TB (0.79 l kg-1) whereas the unbound volume of distribution of PX (1.18 l kg-1) was similar to that of CA (1.06 l kg-1).

References

Jul 1, 1978·Clinical Pharmacokinetics·R I Ogilvie
Aug 1, 1979·Journal of Pharmaceutical Sciences·L Z Benet, R L Galeazzi
Apr 1, 1985·Clinical Pharmacology and Therapeutics·C A ShivelyE S Vesell
Jan 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E RennerR Preisig
Oct 1, 1983·Clinical Pharmacology and Therapeutics·S M TarkaE S Vesell
Jan 1, 1983·European Journal of Clinical Pharmacology·J Blanchard, S J Sawers
Apr 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·J Blanchard, S J Sawers
Jan 1, 1981·Pharmacology & Therapeutics·J B Houston
Jul 1, 1982·Clinical Pharmacology and Therapeutics·M BonatiS Garattini

❮ Previous
Next ❯

Citations

Jan 1, 1988·European Journal of Clinical Pharmacology·S HarderP M Shah
Jan 4, 1989·Klinische Wochenschrift·A HolstegeW Gerok
Jul 30, 2010·Archives of Environmental Contamination and Toxicology·Lisbeth E Gómez-Martínez
Mar 1, 1996·General Pharmacology·J O Miners, D J Birkett
Sep 24, 2013·Neurochemistry International·Lisiane O PorciúnculaDenis B Rosemberg
Jun 9, 2001·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·K WaltonA G Renwick
Mar 10, 1998·Annals of Epidemiology·M A KlebanoffD G Wilkins
Dec 24, 2005·Critical Reviews in Food Science and Nutrition·Faidon Magkos, Stavros A Kavouras
May 7, 2013·Annual Review of Nutrition·Samantha Ellam, Gary Williamson
Oct 23, 2013·Nutrients·Rafael FrancoEva Martínez-Pinilla
Jun 10, 2010·Psychopharmacology·Amy YangHarriet de Wit
Feb 20, 2013·Psychopharmacology·Matthew J BaggottHarriet de Wit
Sep 12, 2012·Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment·E RudolphJ König
Feb 27, 2015·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Marc GhannoumUNKNOWN EXTRIP workgroup
Jun 1, 2015·Vascular Pharmacology·Asimina Kerimi, Gary Williamson
Mar 15, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Rishma VidyasagarLaura M Parkes
Mar 18, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Olav A GressnerAxel M Gressner
Jan 8, 2009·Journal of Clinical Pharmacy and Therapeutics·K-Y SengC-L Lim
Sep 21, 2010·Biomedical Chromatography : BMC·Vidya PereraAndrew J McLachlan
Aug 11, 2011·The Journal of Pharmacy and Pharmacology·Vidya PereraAndrew J McLachlan
May 11, 2013·Drug Testing and Analysis·Ricarda JantosGisela Skopp
Dec 3, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·M GajewskaK-W Schramm
Jun 14, 2006·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·E M HowgateA Rostami-Hodjegan
Sep 12, 2015·Journal of Clinical Pharmacology·Tian YuCatherine M T Sherwin
Apr 15, 2015·Translational Psychiatry·N D VolkowD Tomasi
May 11, 2016·Journal of Alzheimer's Disease : JAD·Afonso MoreiraHenrique Barros
Jul 30, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·João P MonteiroBranca M Silva
Sep 10, 2016·Journal of Photochemistry and Photobiology. B, Biology·R S ScurachioD R Cardoso
Jul 28, 2016·Addiction Biology·Cristina Lao-PeregrínEduardo D Martín
Oct 3, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Abbe Maleyki Mhd Jalil, Amin Ismail
Apr 7, 2018·Critical Reviews in Food Science and Nutrition·João MonteiroBranca M Silva
Dec 14, 2006·Therapeutic Drug Monitoring·Véronique MichaudJacques Turgeon
Apr 1, 1995·Clinical Pharmacology and Therapeutics·M R KorrapatiC M Loi
Feb 9, 2018·Neurochemical Research·Simonetta CamandolaMark P Mattson
Apr 6, 2019·Journal of Basic and Clinical Physiology and Pharmacology·Johnson Segun ShowandeTitilayo Oyelola Fakeye
Nov 11, 2018·The Journal of Pharmacology and Experimental Therapeutics·Takanobu MatsuzakiAmin Rostami-Hodjegan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.